Evolution of regorafenib from bench to bedside in colorectal cancer: Is it an attractive option or merely a “me too” drug?

Overview of attention for article published in Cancer Management and Research, March 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

So far, Altmetric has seen 1 YouTube video.

Video abstract of review paper “Evolution of regorafenib from bench to bedside in colorectal cancer: Is it an attractive option…